PPH

Stocks and exchange traded funds (ETFs) fell sharply in morning trading as many investors dumped financials, grab their returns from a six-week rally and head for the hills. The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used […]

Markets and exchange traded funds (ETFs) are responding to the news that Merck & Co. (MRK) is buying Schering-Plough Corp. (SGP) for $41.1 billion in a deal that gives Merck key new businesses, which will also help them trim costs, leading to more job losses. The opinions and forecasts expressed herein are solely those of […]

Mutual funds have been increasingly getting on board with exchange traded funds (ETFs) and the Aston/New Century Absolute Return Fund (ANENX) is no exception. The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an […]

What is a beaten-down global drug industry that has been hit by flagging product development and high fixed costs doing to restructure and regain strength and  what effect will this have on exchange traded funds (ETFs)? The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on […]

Exchange traded fund (ETF) investors can play defense with their fund choices by focusing on areas of the market that hold up better in a downturn than other sectors. Many market analysts believe we are in a recession, defined as two consecutive quarters of a decline in gross domestic product,  so why not look to […]

Johnson & Johnson (JNJ) is posting a 30% jump in third-quarter profits, beating expectations and potentially giving a dose of strength to health care exchange traded funds (ETFs). Higher sales of consumer products and medical devices is boosting company profit, and the absence of a $745 million restructuring charge has helped this company beat the […]

With drug makers making a push for cervical cancer vaccination, the industry is quickly growing and certain ETFs can capture this growth. In a New York Times article, Elisabeth Rosenthal examines how over the past two years, cervical cancer has gone from an obscure disease mostly in poor nations to a great concern in many […]

Exchange traded funds (ETFs) surrounding pharmaceutical companies appear to be mixed up as findings from advanced drug studies pertaining to dementia are inconclusive. Both Elan Corp. (ELN) and Wyeth (WYE) said complete data from the midstage trial of their experimental drug for Alzheimer’s disease supports their decision to move the drug into more advanced studies […]